These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6154787)

  • 1. Improved therapy of myotonia with the lidocaine derivative tocainide.
    Rüdel R; Dengler R; Ricker K; Haass A; Emser W
    J Neurol; 1980; 222(4):275-8. PubMed ID: 6154787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of myotonia with antiarrhythmic drugs.
    Kwieciński H; Ryniewicz B; Ostrzycki A
    Acta Neurol Scand; 1992 Oct; 86(4):371-5. PubMed ID: 1455983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-arrhythmic effect of tocainide (lidocaine congener) on ventricular arrhythmias (author's transl)].
    Kuck KH; Hanrath P; Lubda J; Mathey D; Bleifeld W
    Dtsch Med Wochenschr; 1979 Nov; 104(48):1701-5. PubMed ID: 93043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open clinical studies at a referral center: chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agents.
    Maloney JD; Nissen RG; McColgan JM
    Am Heart J; 1980 Dec; 100(6 Pt 2):1023-30. PubMed ID: 6778190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerance of tocainide during acute and long-term treatment of chronic ventricular arrhythmias.
    Sonnhag C
    Eur J Clin Pharmacol; 1980 Oct; 18(4):301-10. PubMed ID: 6777178
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert.
    Mielke U; Haass A; Sen S; Schmidt W
    J Neurol; 1985; 232(5):271-4. PubMed ID: 3932602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ
    Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
    [No Abstract]   [Full Text] [Related]  

  • 8. Tocainide therapy for refractory ventricular arrhythmias.
    Roden DM; Roden DM; Reele SB; Reele SB; Higgins SB; Higgins SB; Carr RK; Carr RK; Smith RF; Smith RF; Oates JA; Oates JA; Woosley RL; Woosley RL
    Am Heart J; 1980 Jul; 100(1):15-22. PubMed ID: 6770666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocainide for refractory ventricular arrhythmias of myocardial infarction.
    Haffajee CI; Alpert JS; Dalen JE
    Am Heart J; 1980 Dec; 100(6 Pt 2):1013-6. PubMed ID: 6778188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successuful treatment of paramyotonia congenita (Eulenburg): muscle stiffness and weakness prevented by tocainide.
    Ricker K; Haass A; Rüdel R; Böhlen R; Mertens HG
    J Neurol Neurosurg Psychiatry; 1980 Mar; 43(3):268-71. PubMed ID: 6246209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.
    Talon S; De Luca A; De Bellis M; Desaphy JF; Lentini G; Scilimati A; Corbo F; Franchini C; Tortorella P; Jockusch H; Conte Camerino D
    Br J Pharmacol; 2001 Dec; 134(7):1523-31. PubMed ID: 11724759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and antiarrhythmic effects of tocainide in patients with acute myocardial infarction.
    Nyquist O; Forssell G; Nordlander R; Schenck-Gustafsson K
    Am Heart J; 1980 Dec; 100(6 Pt 2):1000-5. PubMed ID: 6778186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tocainide and quinidine on premature ventricular contractions.
    Wasenmiller JE; Aronow WS
    Clin Pharmacol Ther; 1980 Oct; 28(4):431-5. PubMed ID: 6773715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.
    Winkle RA; Mason JW; Harrison DC
    Am Heart J; 1980 Dec; 100(6 Pt 2):1031-6. PubMed ID: 6778191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana?
    Horowitz LN; Morganroth J
    J Am Coll Cardiol; 1987 Feb; 9(2):459-63. PubMed ID: 3100601
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.
    Gottlieb SS; Kukin ML; Medina N; Yushak M; Packer M
    Circulation; 1990 Mar; 81(3):860-4. PubMed ID: 2106401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Electropharmacology of Tocainide, a lidocaine congener.
    Horowitz LN; Josephson ME; Farshidi A
    Am J Cardiol; 1978 Aug; 42(2):276-80. PubMed ID: 685840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ventricular arrhythmias with oral tocainide.
    Young MD; Hadidian Z; Horn HR; Johnson JL; Vassallo HG
    Am Heart J; 1980 Dec; 100(6 Pt 2):1041-5. PubMed ID: 6778193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse hemodynamic effects of antiarrhythmic drugs in congestive heart failure.
    Hammermeister KE
    Circulation; 1990 Mar; 81(3):1151-3. PubMed ID: 2106400
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy with investigational antiarrhythmic drugs.
    Mead RH; Harrison DC
    Med Clin North Am; 1984 Sep; 68(5):1321-37. PubMed ID: 6436596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.